ArticleClinical pharmacokinetics2015

Comment on: "Pharmacokinetics in patients with chronic liver disease and hepatic safety of incretin-based therapies for the management of type 2 diabetes mellitus".

Emanuel Raschi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.